(주)캠프테라퓨틱스

{
  "address": "충북 청주시",
  "ceo_name": "유재훈",
  "certificate": [
    {
      "cert_number": "20200111677",
      "changes": "",
      "disclosure_date": "2020-09-07",
      "first_cert_date": "2020-09-07",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-09-07 ~ 2022-09-06"
    },
    {
      "cert_number": "20220921030005",
      "changes": "",
      "disclosure_date": "2022-09-21",
      "first_cert_date": "2020-09-07",
      "no": "2",
      "type": "혁신성장유형",
      "valid_period": "2022-09-07 ~ 2025-09-06"
    },
    {
      "cert_number": "20250806030072",
      "changes": "",
      "disclosure_date": "2025-08-06",
      "first_cert_date": "2020-09-07",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2025-09-07 ~ 2028-09-06"
    }
  ],
  "company_name": "(주)캠프테라퓨틱스",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 55500000,
      "cost_of_sales": 0,
      "current_assets": 156176000,
      "current_liabilities": 1096000,
      "gross_profit": 3000000,
      "net_income": -74412000,
      "net_income_bs": -74412000,
      "non_current_assets": 102896000,
      "non_current_liabilities": 2225000,
      "non_operating_expenses": 0,
      "non_operating_income": 3217000,
      "operating_profit": -77629000,
      "revenue": 3000000,
      "sga_expenses": 80629000,
      "total_assets": 259072000,
      "total_equity": 255751000,
      "total_liabilities": 3321000
    },
    "2023": {
      "capital_stock": 55500000,
      "cost_of_sales": 0,
      "current_assets": 48690000,
      "current_liabilities": 381000,
      "gross_profit": 0,
      "net_income": -110720000,
      "net_income_bs": -110720000,
      "non_current_assets": 102896000,
      "non_current_liabilities": 6175000,
      "non_operating_expenses": 3047000,
      "non_operating_income": 5443000,
      "operating_profit": -113116000,
      "revenue": 0,
      "sga_expenses": 113116000,
      "total_assets": 151587000,
      "total_equity": 145031000,
      "total_liabilities": 6556000
    },
    "2024": {
      "capital_stock": 57166000,
      "cost_of_sales": 0,
      "current_assets": 116440000,
      "current_liabilities": 34616000,
      "gross_profit": 0,
      "net_income": -295270000,
      "net_income_bs": -295270000,
      "non_current_assets": 119372000,
      "non_current_liabilities": 201863000,
      "non_operating_expenses": 7449000,
      "non_operating_income": 1547000,
      "operating_profit": -289368000,
      "revenue": 0,
      "sga_expenses": 289368000,
      "total_assets": 235813000,
      "total_equity": -666000,
      "total_liabilities": 236479000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "펩타이드 약물(미토콘드리아 특이적 펩타이드, 세포투과성 펩타이드, 항균 감응 펩타이드)",
  "phone": "010-2062-****",
  "years": [
    2024,
    2023,
    2022
  ]
}